InformationWeek is part of the Informa Tech Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them.Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
User Rank: Apprentice
10/26/2011 | 7:43:21 PM
D+¬j+á vu All Over Again GÇô The Mobile Testing Nightmare
http://www.robertvbinder.com/b...
Competent, Mediocre, or Dangerous?
http://www.robertvbinder.com/b...
The short version: I think the FDA has gotten the general requirements for developing high reliability software-intensive products about right, but the onus for achieving this high quality is on the development organizations. There is wide variation in interpretation, which can lead to inadequate development practices.
I don't see any essential difference in the general requirements for developing high quality systems with mobile endpoints. However, verification and validation of a system with mobile endpoints is *more* difficult than a wired client/server system, other things being equal. Owing to lack of experience, many assume that mobile endpoints are easier to develop/test.
The new FDA Guidance delimits when mobile platforms are considered as part of regulated system or not. I don't see anything in the guidance that calls for a different approach to developing, verifying, or validating included systems. The criteria for inclusion of a mobile endpoint seems to be that if it supports a feature which is regulated, then the mobile endpoint is also regulated.
I hope that developers using mobile end-points for regulated systems will take the unique challenges of mobile in to account in planning their V&V.
Bob Binder